Understanding the mechanisms that turn sets of genes on or off is a fundamental quest in biology, and one that has clinical importance in diseases like cancer, where gene control goes awry.
David M. Bedwell, Ph.D., has been named the chair of the Department of Biochemistry and Molecular Genetics. He has been leading the department as its interim chair since February 2016.
This novel method improves purification of complex proteins by 10- to 500-fold, and it may aid both research and large-scale industrial production.
Allostery, a fundamental means of regulating enzymes, is crucial for living cells.
The award recognizes a significant paper by Cui in Cell Death and Differentiation.
Five faculty members in the School of Medicine have been named the 2016 class of James A. Pittman Jr., M.D., Scholars, a program organized to recognize the contributions of junior faculty and support the retention of highly competitive scientists and physician-scientists.
UAB and UMass researchers have uncovered a new mechanistic understanding of potential treatment for genetic disorders.
Improved production of stem cells is vital if they are to achieve their promise for medical research and disease treatments like transplantation, creating patient-specific cell-replacement therapies to treat neurological diseases, heart ailments, blood diseases and diabetes.
Greater efficiency is a must for future clinical use of these cells in regenerative medicine, drug screening and disease study.
David M. Bedwell, Ph.D., professor in the Department of Microbiology and associate director of the Gregory Fleming James Cystic Fibrosis Center, has been named the interim chair of the UAB Department of Biochemistry and Molecular Genetics.
Page 1 of 3